Schroder Investment Management Group
CRBP icon

Schroder Investment Management Group’s Corbus Pharmaceuticals CRBP Stock Holding History

Schroder Investment Management Group’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-31,295
Closed -$173K – 1183
2025
Q1 		$173K Hold
31,295
– – ﹤0.01% 1171
2024
Q4 		$378K Hold
31,295
– – ﹤0.01% 1129
2024
Q3 		$655K Sell
31,295
-33,208
-51% -$1.7M ﹤0.01% 1078
2024
Q2 		$2.92M Hold
64,503
– – ﹤0.01% 881
2024
Q1 		$2.53M Buy
+64,503
New +$1.59M ﹤0.01% 893

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return

Schroder Investment Management Group's CRBP Position: Q2 2025 in Review

Schroder Investment Management Group sold out of Corbus Pharmaceuticals (CRBP) in Q2 2025, closing a stake of 31,295 shares — an estimated $173K sold.

Schroder Investment Management Group first reported a position in CRBP in Q1 2024 and held it in 5 quarters. The position peaked at $2.92M in Q2 2024. 80 funds tracked by Wall St. Rank hold CRBP as of Q2 2025.

  • Schroder Investment Management Group reported no remaining Corbus Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Schroder Investment Management Group sold 31,295 Corbus Pharmaceuticals shares in Q2 2025, an estimated $173K.
  • Schroder Investment Management Group first reported a position in Corbus Pharmaceuticals in Q1 2024 and held it in 5 quarters.
  • Schroder Investment Management Group's Corbus Pharmaceuticals position peaked at $2.92M in Q2 2024.
  • 80 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2025.

Based on Schroder Investment Management Group's 13F filing for Q2 2025, filed 13 Aug 2025.